View in EDS

Real‐Life Effectiveness After Switching to Avalglucosidase Alfa in Late‐Onset Pompe Disease Patients Worsening on Alglucosidase Alfa Therapy: A French Cohort Study.

Saved in:
Bibliographic Details
Title: Real‐Life Effectiveness After Switching to Avalglucosidase Alfa in Late‐Onset Pompe Disease Patients Worsening on Alglucosidase Alfa Therapy: A French Cohort Study.
Authors: Tard, Céline1,2 (AUTHOR) celine.tard@chru‐lille.fr, Sacconi, Sabrina3 (AUTHOR), Taouagh, Nadjib2,4 (AUTHOR), Bouhour, Françoise5,6 (AUTHOR), Michaud, Maud2,7 (AUTHOR), Beltran, Stephane8 (AUTHOR), Fournier, Maxime2,9 (AUTHOR), Demurger, Florence10 (AUTHOR), Lagrange, Emmeline11 (AUTHOR), Nollet, Sylvain2,12 (AUTHOR), Noury, Jean‐Baptiste13,14 (AUTHOR), Magot, Armelle13,15 (AUTHOR), Cintas, Pascal16 (AUTHOR), Renard, Dimitri13,17 (AUTHOR), Deibener‐Kaminsky, Joëlle18 (AUTHOR), Lefeuvre, Claire2,4 (AUTHOR), Davion, Jean‐Baptiste1,2 (AUTHOR), Salort‐Campana, Emmanuelle6,19 (AUTHOR), Arrassi, Azzeddine20 (AUTHOR), Spinazzi, Marco21 (AUTHOR)
Source: European Journal of Neurology. Jul2026, Vol. 33 Issue 7, p1-8. 8p.
Database: Academic Search Ultimate
Description
ISSN:13515101
DOI:10.1111/ene.70680